175 related articles for article (PubMed ID: 29373490)
21. Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer.
Vaidya B; Parvathaneni V; Kulkarni NS; Shukla SK; Damon JK; Sarode A; Kanabar D; Garcia JV; Mitragotri S; Muth A; Gupta V
Int J Biol Macromol; 2019 Feb; 122():338-347. PubMed ID: 30401652
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of paclitaxel-loaded polymeric nanoparticles in 3D tumor model: impact of tumor stroma on penetration and efficacy.
Priwitaningrum DL; Pednekar K; Gabriël AV; Varela-Moreira AA; Le Gac S; Vellekoop I; Storm G; Hennink WE; Prakash J
Drug Deliv Transl Res; 2023 May; 13(5):1470-1483. PubMed ID: 36853438
[TBL] [Abstract][Full Text] [Related]
23. Inkjet printing of antiviral PCL nanoparticles and anticancer cyclodextrin inclusion complexes on bioadhesive film for cervical administration.
Varan C; Wickström H; Sandler N; Aktaş Y; Bilensoy E
Int J Pharm; 2017 Oct; 531(2):701-713. PubMed ID: 28432016
[TBL] [Abstract][Full Text] [Related]
24. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level.
Ercan A; Çelebier M; Oncul S; Varan G; Kocak E; Benito JM; Bilensoy E
Int J Pharm; 2021 Apr; 598():120379. PubMed ID: 33592288
[TBL] [Abstract][Full Text] [Related]
25. 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.
Daunys S; Janonienė A; Januškevičienė I; Paškevičiūtė M; Petrikaitė V
Adv Exp Med Biol; 2021; 1295():243-270. PubMed ID: 33543463
[TBL] [Abstract][Full Text] [Related]
26. Cyclodextrin nanosponge as a temoporfin nanocarrier: Balancing between accumulation and penetration in 3D tumor spheroids.
Yakavets I; Guereschi C; Lamy L; Kravchenko I; Lassalle HP; Zorin V; Bezdetnaya L
Eur J Pharm Biopharm; 2020 Sep; 154():33-42. PubMed ID: 32634570
[TBL] [Abstract][Full Text] [Related]
27. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation
Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z
J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390
[No Abstract] [Full Text] [Related]
28. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
Parrot-Lopez H; Perret F; Bertino-Ghera B
Ann Pharm Fr; 2010 Jan; 68(1):12-26. PubMed ID: 20176159
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-Loaded TPGS
Zou L; Zhang Z; Feng J; Ding W; Li Y; Liang D; Xie T; Li F; Li Y; Chen J; Yang X; Tang L; Ding W
J Pharm Sci; 2022 Jun; 111(6):1776-1784. PubMed ID: 35341722
[TBL] [Abstract][Full Text] [Related]
30. Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.
Evans JC; Malhotra M; Fitzgerald KA; Guo J; Cronin MF; Curtin CM; O'Brien FJ; Darcy R; O'Driscoll CM
Mol Pharm; 2017 Jan; 14(1):42-52. PubMed ID: 28043128
[TBL] [Abstract][Full Text] [Related]
31. AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.
Godugu C; Patel AR; Desai U; Andey T; Sams A; Singh M
PLoS One; 2013; 8(1):e53708. PubMed ID: 23349734
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic evaluation of injectable cyclodextrin nanoparticles.
Memisoglu-Bilensoy E; Doğan AL; Hincal AA
J Pharm Pharmacol; 2006 May; 58(5):585-9. PubMed ID: 16640826
[TBL] [Abstract][Full Text] [Related]
33. Modification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-β-cyclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injection.
Baek JS; Kim JH; Park JS; Cho CW
Int J Nanomedicine; 2015; 10():5397-405. PubMed ID: 26347363
[TBL] [Abstract][Full Text] [Related]
34. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles.
Bilensoy E; Hincal AA
Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965
[TBL] [Abstract][Full Text] [Related]
35. Design and Characterization of Carboplatin and Paclitaxel Loaded PCL Filaments for 3D Printed Controlled Release Intrauterine Implants.
Varan C; Aksüt D; Şen M; Bilensoy E
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111639
[TBL] [Abstract][Full Text] [Related]
36. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer.
Wang X; Parvathaneni V; Shukla SK; Kulkarni NS; Muth A; Kunda NK; Gupta V
Int J Biol Macromol; 2020 Dec; 164():638-650. PubMed ID: 32693132
[TBL] [Abstract][Full Text] [Related]
37. Concave microwell array-mediated three-dimensional tumor model for screening anticancer drug-loaded nanoparticles.
Kang A; Seo HI; Chung BG; Lee SH
Nanomedicine; 2015 Jul; 11(5):1153-61. PubMed ID: 25752856
[TBL] [Abstract][Full Text] [Related]
38. Dual-drug nanomedicine with hydrophilic F127-modified magnetic nanocarriers assembled in amphiphilic gelatin for enhanced penetration and drug delivery in deep tumor tissue.
Lai YH; Chiang CS; Kao TH; Chen SY
Int J Nanomedicine; 2018; 13():3011-3026. PubMed ID: 29861633
[TBL] [Abstract][Full Text] [Related]
39. A Promising Review on Cyclodextrin Conjugated Paclitaxel Nanoparticles for Cancer Treatment.
Velhal K; Barage S; Roy A; Lakkakula J; Yamgar R; Alqahtani MS; Yadav KK; Ahn Y; Jeon BH
Polymers (Basel); 2022 Aug; 14(15):. PubMed ID: 35956677
[TBL] [Abstract][Full Text] [Related]
40. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models.
Foglietta F; Spagnoli GC; Muraro MG; Ballestri M; Guerrini A; Ferroni C; Aluigi A; Sotgiu G; Varchi G
Int J Nanomedicine; 2018; 13():4847-4867. PubMed ID: 30214193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
